Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Johnson and Johnson
Farmers Insurance
Healthtrust
Express Scripts
Fish and Richardson
McKinsey
QuintilesIMS

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074132

« Back to Dashboard

NDA 074132 describes NORTRIPTYLINE HYDROCHLORIDE, which is a drug marketed by Aurolife Pharma Llc, Idt Australia Ltd, Mayne Pharma, Mylan, Taro Pharm, Teva, Pharm Assoc, and Taro, and is included in nine NDAs. It is available from twenty-five suppliers. Additional details are available on the NORTRIPTYLINE HYDROCHLORIDE profile page.

The generic ingredient in NORTRIPTYLINE HYDROCHLORIDE is nortriptyline hydrochloride. There are eleven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the nortriptyline hydrochloride profile page.
Summary for 074132
Tradename:NORTRIPTYLINE HYDROCHLORIDE
Applicant:Teva
Ingredient:nortriptyline hydrochloride
Patents:0
Therapeutic Class:Antidepressants
Formulation / Manufacturing:see details
Pharmacology for NDA: 074132
Medical Subject Heading (MeSH) Categories for 074132
Suppliers and Packaging for NDA: 074132
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074132 ANDA Teva Pharmaceuticals USA, Inc. 0093-0810 N 0093-0810-01
NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074132 ANDA Teva Pharmaceuticals USA, Inc. 0093-0810 N 0093-0810-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 10MG BASE
Approval Date:Mar 27, 1995TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 25MG BASE
Approval Date:Mar 27, 1995TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 50MG BASE
Approval Date:Mar 27, 1995TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Covington
Cerilliant
Deloitte
Dow
Queensland Health
Johnson and Johnson
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.